Immunotherapy + greed

The New York Times reports on an emerging new cancer drug that is being co-developed by the US government and a private pharmaceutical company.  The cancer treatment is a form of immunotherapy called CAR-T where T cells are activated to fight cancer.  The new cancer therapy, a one-time treatment, is expetect to cost $200,000 per patient.  The stock price for the company developing the CAR-T therapy is said to be $50/share with no product yet.  Government is sharing the costs, and then will pay via Medicare for the treatment, and the pharmaceutical company will kick back a small royalty.  The pharmaceutical company’s leadership can be characterized as a mix of greed, ego and charlatanism.  [New York Times Dec 19, 2016]  Sounds like Theranos all over again.

Continue reading Immunotherapy + greed

Male birth control injection somewhat effective

Injection of sex hormones in males lowered sperm counts to less than 1 million per milliliter or less in 274 of 320 men after 24 weeks.  This male birth control shot was found to be effective in nearly 96% of users.  Side effects included mental depression, mood changes and increased libido.  Twenty men dropped out of the study because of side effects such as heart palpitations, high blood pressure and erectile dysfunction.  [Medical News Today Oct 28, 2016]  This is not ready for prime time regardless of whatever positive news you may read.